09/13/2021

Expanding Access to COVID-19 Therapeutics

State of Ohio Board of Pharmacy Update

The State of Ohio Board of Pharmacy released an update on 9/10/21 announcing federal steps to expand access to COVID-19 therapeutics and clarifying the role of pharmacists and pharmacy technicians and interns.

The memo states "to promote access to therapeutics to treat COVID-19, the Department of Health and Human Services (HHS) amended the Public Readiness and Emergency Preparedness (PREP) Act declaration
to provide liability protection to licensed pharmacists, pharmacy technicians*, and pharmacy
interns."  By expanding PREP Act coverage to include these trained professionals for the administration of covered COVID-19 therapeutics, HHS is providing a pathway for increased access to COVID-19 therapeutics, particularly in surge states with rising numbers of COVID-19 cases and in rural areas where access to inpatient and outpatient services may be more limited. 

View the full Board of Pharmacy release for more information on who's covered and other important details.